Shots:

• VESIcare LS is an oral suspension dosage prescribed medicine specifically developed to facilitate dosing and administration for children 2 years of age and older with a condition called neurogenic detrusor overactivity
• In 2004- the VESIcare LS initially approved in the US while its oral suspension will come in a 5 mg/5 mL (1 mg/mL) oral suspension and will be available in US in late 2020- available in EU
• The product is usulaly used for the reduction of urine your bladder can hold and reduce urine leakage

Click here to read full press release/ article | Ref: Astellas | Image: Astellas